The Digital Health Advisory Committee is tasked with providing perspective and recommendations on a wide variety of topics. These insights will then help the FDA draft new policies and make other important decisions.

Cardiologist Dan Blumenthal, MD, MBA, explains how changes in Medicare payments will greatly impact cardiology in the years ahead. In just a few short years, the business side of cardiology could look substantially different than it does today. 

Novolink Health, previously known as Duxlink Health, has a decade of experience treating high-risk, high-cost patients from the comfort of their own homes. It will now function as a division within Florida-based Cardiovascular Associates of America.

The Danish pharmaceutical company said it will resubmit its application in 2025 to have Wegovy approved for use in heart failure patients.

Medtronic and Abbott are often seen as rivals in a competitive marketplace, but the two companies are collaborating with a simple goal in mind: improving patient access to high-quality CGM devices. 

It’s easy to forget that generative AI launched into the economy—and the public imagination—less than two years ago. How could it be otherwise?

Patient safety should be the No. 1 consideration for healthcare organizations working, planning or hoping to adopt AI. Then again, nine other concerns are similarly crucial to the success of the industry-wide endeavor.

This partnership reflects NextGen Healthcare’s deepening commitment to supporting cardiology practices nationwide. Research shows that nearly 50 percent of adults in the United States have some form of cardiovascular disease today—a rate expected to grow to 61 percent by 2050.